---
title: "Major Aveanna Stakeholders Quietly Unload Massive Positions"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291620130.md"
description: "Major shareholders of Aveanna Healthcare Holdings (AVAH) significantly reduced their positions in early July 2026, with Paul Vigano and Robert M. Williams each selling 3 million shares, and J.H. Whitney Equity Partners VII selling over 2.4 million shares. Despite this insider selling, RBC Capital upgraded the stock citing strong execution and valuation, while TipRanks' AI analyst maintains a Neutral rating due to high leverage risks."
datetime: "2026-07-03T02:04:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291620130.md)
  - [en](https://longbridge.com/en/news/291620130.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291620130.md)
---

# Major Aveanna Stakeholders Quietly Unload Massive Positions

New insider activity at Aveanna Healthcare Holdings ( (AVAH) ) has taken place on July 2, 2026.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Aveanna Healthcare Holdings has seen a flurry of selling activity from its significant shareholders. Paul Vigano disposed of 3,000,000 shares in a transaction valued at $24,030,000. Likewise, fellow significant shareholder Robert M. Williams sold 3,000,000 shares, also for a total of $24,030,000. In addition, J.H. Whitney Equity Partners VII, LLC reduced its position by 2,419,035 shares, generating proceeds of $19,376,470. Together, these moves represent a substantial divestment by key stakeholders in the company.

**Recent Updates on AVAH stock**

Aveanna Healthcare Holdings shares reacted to an analyst upgrade from RBC Capital within the last 24 hours, driven by confidence in the company’s solid execution on preferred payor relationships and an expanded private duty nursing footprint following the Family First acquisition.

The firm argued that policy uncertainty and reimbursement worries have pressured the stock excessively despite Aveanna’s growing market presence and improving preferred payor mix, which it believes should help buffer the company against Medicaid policy turbulence as the shares trade near trough valuation levels.

**Spark’s Take on AVAH Stock**

According to Spark, TipRanks’ AI Analyst, AVAH is a Neutral.

AVAH scores above average primarily due to improving operations and upbeat forward outlook (raised 2026 guidance and strong recent growth), supported by a low P/E valuation. The biggest offset is financial risk from high leverage and limited debt coverage, while technicals show strong trend strength but overbought conditions that can increase near-term volatility.

To see Spark’s full report on AVAH stock,  
click here.

**More about Aveanna Healthcare Holdings**

**YTD Price Performance:** 8.45%

**Average Trading Volume:** 1,741,434

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** $1.93B

### Related Stocks

- [AVAH.US](https://longbridge.com/en/quote/AVAH.US.md)

## Related News & Research

- [Aveanna Healthcare Issues 2026 Outlook, Highlights Growth](https://longbridge.com/en/news/286570705.md)
- [Aveanna posts $2.54–$2.56B 2026 revenue guidance, $318–$322M adjusted EBITDA; Q4 2025 revenue +27% and strong cash flow](https://longbridge.com/en/news/279935694.md)
- [Berenberg Bank upgrades MERSEN (0Q6Q) to a Buy](https://longbridge.com/en/news/294649631.md)
- [Aveanna Healthcare Posts Strong Q4, Affirms 2026 Outlook](https://longbridge.com/en/news/279777441.md)
- [J.P. Morgan Sticks to Their Buy Rating for Vonovia (0QFT)](https://longbridge.com/en/news/294926245.md)